Background & Aims Nonalcoholic fatty liver disease (NAFLD) is traditionally associated with
obesity. However, there is a subtype of NAFLD, namely NAFLD in lean, that occurs without …

Global estimates of prevalence, deaths, and disability-adjusted life years (DALYs) from the
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …

The burden of nonalcoholic fatty liver disease (NAFLD) is rising globally. Cardiovascular
disease is the leading cause of death in patients with NAFLD. Nearly half of individuals with …

Background Fatty liver disease in the absence of excessive alcohol consumption is an
increasingly common condition with a global prevalence of~ 25–30% and is also associated …

Methods Data from the National Health and Nutrition Examination Survey 1999–2018 was
used. Hepatic steatosis was defined with United States Fatty Liver Index (US-FLI) and FLI at …

Background and aims Hypertension (HTN) is a common comorbidity in non-alcoholic fatty
liver disease (NAFLD) affecting up to 40% of individuals. However, the impact of HTN and its …

Background & Aims The impact of the severity of sarcopenic obesity (SO) in nonalcoholic
fatty liver disease (NAFLD) on the risk of significant liver fibrosis or cardiovascular disease …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by excess
fat accumulation in the liver. It is closely associated with metabolic syndrome, and patients …

Aim To examine the prevalence and prognosis of hepatic steatosis and fibrosis in post‐
acute myocardial infarction (AMI) patients. Methods Patients presenting with AMI to a tertiary …

Background Evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated
with cardiovascular diseases (CVDs). However, the results are inconsistent, and the …